Live Breaking News & Updates on Xortx Therapeutics Inc Stock Exchange

Stay updated with breaking news from Xortx therapeutics inc stock exchange. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

XORTX Therapeutics : NOTICE OF ANNUAL & SPECIAL MEETING OF SHAREHOLDERS - Form 6-K

NOTICE OF ANNUAL & SPECIAL MEETING OF SHAREHOLDERS

NOTICE IS HEREBY GIVEN that the annual and special meeting of the shareholders of XORTX Therapeutics Inc. will be held. | May 30, 2023 ....

Anthony Giovinazzo , Therapeutics Inc , Company Common , Record Date , Common Shares , Xortx Therapeutics Inc Stock Exchange , Press Release , E Xrtx Ca98420q2071 ,

XORTX Therapeutics : Annual Information Form

XORTX THERAPEUTICS INC.

ANNUAL INFORMATION FORM

FOR THE FISCAL YEAR ENDED DECEMBER 31, 2022

MARCH 31, 2023

. | April 1, 2023 ....

United States , Therapeutics Inc , Orphan Drug Designation , Xortx Therapeutics Inc Stock Exchange , Press Release , Arch Xrtx Ca98420q2071 ,

XORTX Announces Positive Topline Results from XRX-OXY-101 Clinical Trial

CALGARY, Alberta, Jan. 19, 2023 XORTX Therapeutics Inc. , a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is. | January 19, 2023 ....

United States , Nick Rigopulos , Allen Davidoff , David Melamed , Company Xrx , Therapeutics Inc , Bridging Pharmacokinetics Clinical Trial , Kidney Disease , Polycystic Kidney Disease , Nat Rev Dis , Nat Rev Nephrol , Xortx Therapeutics Inc Stock Exchange , Press Release , Idney Xrtx Ca98420q2071 ,

XORTX Presents New Proof of Concept Data at American Society of Nephrology

● Xanthine Oxidase Inhibition with XRx-008 Blocks Uric Acid Induced Increasein Total Kidney Weight in Polycystic Kidney Disease ● CALGARY, Alberta, Nov. 03, 2022 XORTX. | November 3, 2022 ....

United States , Allen Davidoff , Charles Edelstein , Company Xrx , Association Of Nephrolithiasis , University Of Colorado , Therapeutics Inc , American Society Of Nephrology , Venture Exchange , Xanthine Oxidase Inhibition , Uric Acid Induced , Total Kidney Weight , Polycystic Kidney Disease , American Society , Annual Conference , Serum Uric Acid , Uricase Inhibitor Worsens , Session Title , Genetic Diseases , Xanthine Oxidase , Orphan Drug Designation , Kidney Week Conference , Kidney Week , Kidney Disease , Nat Rev Dis , Nat Rev Nephrol ,

XORTX to Present at LD Micro Invitational 2022

CALGARY, Alberta, June 08, 2022 XORTX Therapeutics Inc. , a late stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased. | June 8, 2022 ....

Nick Rigopulos , Allen Davidoff , Exchange Commission , Therapeutics Inc , Seasons Hotel Westlake Village , Venture Exchange , Globenewswire Inc , Autosomal Dominant Polycystic Kidney Disease , Annual Information Form , Management Discussion , Xortx Therapeutics Inc Stock Exchange , Press Release , S Xrtx Ca98420q2071 ,